Cargando…

Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer

Immunotherapies, such as immune-checkpoint blockade and adoptive T-cell therapy, offer novel treatment options with good efficacy for patients with urothelial bladder cancer. However, heterogeneity and therapeutic resistance have limited the use of immunotherapy. Further research into immune-regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tianhang, Liu, Tianyao, Zhao, Zihan, Pan, Yuchen, Xu, Xinyan, Zhang, Yulin, Zhan, Shoubin, Zhou, Shengkai, Zhu, Wenjie, Guo, Hongqian, Yang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483128/ https://www.ncbi.nlm.nih.gov/pubmed/36131933 http://dx.doi.org/10.3389/fimmu.2022.911325

Ejemplares similares

The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities
por: Li, Tianhang, et al.
Publicado: (2022)

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2023)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
por: Li, Tianhang, et al.
Publicado: (2023)

Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2022)

Evaluating adipose‐derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer
por: Liu, Tianyao, et al.
Publicado: (2022)

Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
por: Li, Tianhang, et al.
Publicado: (2021)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity
por: Tang, Juan, et al.
Publicado: (2018)

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
por: Tang, Qi, et al.
Publicado: (2023)

Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
por: An, Bingzheng, et al.
Publicado: (2022)

Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma
por: Yan, Xin, et al.
Publicado: (2022)

C-Type Lectin Receptors-Triggered Antifungal Immunity May Synergize with and Optimize the Effects of Immunotherapy in Hepatocellular Carcinoma
por: Xia, Jinkun, et al.
Publicado: (2023)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
por: Chen, Hualin, et al.
Publicado: (2022)

Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy
por: Benjamin, David J., et al.
Publicado: (2023)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
por: Zhou, Min, et al.
Publicado: (2023)

CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
por: Zhu, Wenjie, et al.
Publicado: (2021)

Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder
por: Yang, Meihua, et al.
Publicado: (2022)

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder
por: Feng, Huan, et al.
Publicado: (2023)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762
por: Liu, Tianyao, et al.
Publicado: (2020)

Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023)

Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer
por: Daza-Cajigal, Vanessa, et al.
Publicado: (2019)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

The era of personalized treatments: Updates on immunotherapy within urothelial of bladder cancer
por: Wu, Zhang-Song, et al.
Publicado: (2022)

Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
por: Kim, Ryul, et al.
Publicado: (2022)

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer
por: Xu, Chao, et al.
Publicado: (2023)

Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
por: Zhao, Zihan, et al.
Publicado: (2020)

Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p
por: Li, Tianhang, et al.
Publicado: (2022)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
por: Zang, Jingyu, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

C-Type Lectin Receptors in Asthma
por: Hadebe, Sabelo, et al.
Publicado: (2018)

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
por: Romero, Irene, et al.
Publicado: (2018)

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection
por: Munari, Enrico, et al.
Publicado: (2022)

Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an in vitro interstitial cystitis/bladder pain syndrome model
por: Kuret, Tadeja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjmh5ovpl82pjndvndmft5av8t